Press Releases

Sengenics Partners with Olivia Newton-John Cancer Research Institute to Enhance Safety of Cancer Immunotherapy Drugs

Sengenics, the functional proteomics company, today announced signing of a collaboration agreement with the Olivia Newton-John Cancer Research Institute (ONJCRI) focusing on profiling Immune-related Adverse Events (irAEs) using the patented…

more INFO »

Sengenics Announces e-sales of KREX™-based Protein Arrays for Researchers Worldwide

Sengenics, the functional proteomics company, today announced the retail product launch of…

more INFO »

Sengenics Strengthens Commitment to Cancer Diagnostics and Treatment Development, Becomes Oslo Cancer Cluster Member

Sengenics, the functional proteomics company, today announced joining the Oslo Cancer Cluster,…

more INFO »

Sengenics Launches New Autoantibody Biomarker Database to Enhance Development of Diagnostics and Therapeutics

Sengenics, the functional proteomics company, today announced the launch of its new…

more INFO »

Sengenics Announces Launch of ProSys Custom Protein Expression Service using Patented Immunome Technology Platform

Sengenics, an immuno-diagnostics and therapeutics biotechnology company, today announced the launch of…

more INFO »

Sengenics Launches iTAP Technology Access Program

Sengenics, an immuno-diagnostics and therapeutics biotechnology company, today announced the launch of…

more INFO »

Sengenics Announces Application Diversification Phase

Sengenics today announced five new applications of its patented Immunome Protein Array…

more INFO »

Sengenics Announces Commercial Partnership

Sengenics, a genomics and proteomics-based research and diagnostics services company and Raybiotech,…

more INFO »

Sengenics Launches New Genomics and Immunomics Facility

Sengenics, a genomics and proteomics-based research and diagnostics company, announced today the…

more INFO »

Genome Institute of Singapore and Sengenics

Genome Institute of Singapore and Sengenics Enter Into Partnership for Early Detection…

more INFO »

CollabRx, Sengenics Partner on Cancer Diagnostics

CollabRx today announced a deal with Sengenics to incorporate each other's products…

more INFO »

Sengenics to Launch Global Biomarker Discovery

Sengenics to Launch Global Biomarker Discovery and Clinical Trials Service Based on…

more INFO »
X